About NEULASTA

NEULASTA is a medication used to help prevent severe neutropenia, a condition characterized by an abnormally low count of neutrophils, a type of white blood cell. It is specifically designed for patients undergoing chemotherapy, which can cause a decrease in neutrophil production, increasing the risk of infections.

Key Benefits & Uses

Prevents severe neutropenia in patients receiving chemotherapy
Reduces the risk of infections in patients with low neutrophil counts
Helps maintain a stable white blood cell count during chemotherapy treatment

Active Ingredient & Action

NEULASTA contains the active ingredient PEGFILGRASTIM, a recombinant human granulocyte-colony stimulating factor (G-CSF) analog. PEGFILGRASTIM works by stimulating the bone marrow to produce more neutrophils, thereby increasing the white blood cell count and reducing the risk of infections.

Important Notes

NEULASTA should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions to minimize the risk of side effects. Patients with a history of serious allergic reactions or hypersensitivity to PEGFILGRASTIM should not use NEULASTA. As with any medication, it is crucial to discuss any concerns or questions with a healthcare provider before starting treatment.